Literature DB >> 1705512

The effect of interleukin 3 upon IgE-dependent and IgE-independent basophil degranulation and leukotriene generation.

Y Kurimoto1, A L De Weck, C A Dahinden.   

Abstract

Recent investigations have shown that the hematopoietic growth factor interleukin 3 (IL 3) enhances histamine release of mature human basophils. Furthermore, basophils exposed to IL 3 generate large amounts of leukotriene C4 in response to C5a, a basophil agonist which by itself is unable to promote lipid mediator formation. Also IL 3 renders the cells responsive to factors which do not otherwise induce basophil mediator release. Here we show in more detail how IL 3 affects the release of preformed and newly synthesized inflammatory mediators by basophils in response to antigen, anti-IgE, N-formyl-methionyl-leucyl-phenylalanine (FMLP) and C5a. In cells triggered by maximally effective concentrations of these agonists, IL 3 enhances histamine release, although it more profoundly affects leukotriene generation, in particular in response to stimuli which by themselves are inefficient or poor inducers of lipid mediator formation. This change in the mediator-release reaction occurs at low IL 3 concentrations, over the same concentration range of IL 3 of 0.01-1.0 U/ml regardless of which triggering agent is used as a second signal. Pretreatment of basophils with IL 3 results in a left shift of the dose-response curves for mediator release of both IgE-dependent and IgE-independent agonists by approximately one order of magnitude. IL 3 affects only the extent and not the time course of IgE-independent peptide-induced basophil degranulation. By contrast, histamine and leukotrienes are released more rapidly in response to IgE-dependent stimulation after IL 3 priming. IL 3 also shortens the lag time and increases the rate of leukotriene generation in basophils triggered by FMLP. The priming process induced by IL 3 does not require extracellular calcium. Basophils exposed to IL 3 release significant amount of mediators in response to C5a, even in EDTA buffers without addition of Ca2+/Mg2+, indicating that in the presence of IL 3 the Ca2(+)-dependent mediator release induced by C5a becomes partially Ca2+ independent. Thus, we find that IL 3 strongly affects the mediator profile, the amounts of mediators released, the dose-response curves and the kinetic of the release reaction in basophils stimulated with diverse agonists. The data further support the hypothesis that IL 3 plays an important role in inflammatory processes, in particular in hypersensitivity reactions.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1705512     DOI: 10.1002/eji.1830210217

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  20 in total

Review 1.  Basophils and type 2 immunity.

Authors:  Booki Min; William E Paul
Journal:  Curr Opin Hematol       Date:  2008-01       Impact factor: 3.284

2.  Regulation of human basophil activation; the role of Na+ and Ca2+ in IL-3-induced potentiation of IgE-mediated histamine release from human basophils.

Authors:  F Beauvais; K Echasserieau; C Burtin; J Benveniste
Journal:  Clin Exp Immunol       Date:  1994-01       Impact factor: 4.330

Review 3.  Pros and Cons of Clinical Basophil Testing (BAT).

Authors:  Hans Jürgen Hoffmann; Edward F Knol; Martha Ferrer; Lina Mayorga; Vito Sabato; Alexandra F Santos; Bernadette Eberlein; Anna Nopp; Donald MacGlashan
Journal:  Curr Allergy Asthma Rep       Date:  2016-07       Impact factor: 4.806

4.  Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamine-releasing factors.

Authors:  Ilona Kleine Budde; Pleuni G de Heer; Susanne Natter; Vera Mahler; Jaring S van der Zee; Rudolf Valenta; Rob C Aalberse
Journal:  Immunology       Date:  2002-10       Impact factor: 7.397

5.  Omalizumab increases the intrinsic sensitivity of human basophils to IgE-mediated stimulation.

Authors:  Donald W Macglashan; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2013-06-20       Impact factor: 10.793

6.  Interactions of IFN-gamma with IL-3 and IL-4 in the regulation of serotonin and arachidonate release from mouse peritoneal mast cells.

Authors:  M R Holliday; E M Banks; R J Dearman; I Kimber; J W Coleman
Journal:  Immunology       Date:  1994-05       Impact factor: 7.397

Review 7.  Physiological and pathophysiological functions of intestinal mast cells.

Authors:  Stephan C Bischoff
Journal:  Semin Immunopathol       Date:  2009-06-17       Impact factor: 9.623

8.  Effect of c-kit ligand, stem cell factor, on mediator release by human intestinal mast cells isolated from patients with inflammatory bowel disease and controls.

Authors:  S C Bischoff; S Schwengberg; K Wordelmann; A Weimann; R Raab; M P Manns
Journal:  Gut       Date:  1996-01       Impact factor: 23.059

9.  Release of sulfidoleukotrienes in vitro: its relevance in the diagnosis of pseudoallergy to acetylsalicylic acid.

Authors:  W Czech; E Schöpf; A Kapp
Journal:  Inflamm Res       Date:  1995-07       Impact factor: 4.575

10.  Cell proliferation status, cytokine action and protein tyrosine phosphorylation modulate leukotriene biosynthesis in a basophil leukaemia and a mastocytoma cell line.

Authors:  W Hagmann
Journal:  Biochem J       Date:  1994-04-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.